Profiles: Page 2

The latest opinion pieces by industry thought leaders


  • Amit Etkin horizontal
    Image attribution tooltip
    Permission granted by Amit Etkin
    Image attribution tooltip

    Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds

    After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.

    Alexandra Pecci • Oct. 11, 2022
  • A portrait of Jim Lang framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Lang
    Image attribution tooltip

    Red Jacket: Jim Lang

    The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

    PharmaVoice staff • Sept. 15, 2022
  • Header of Peyton Howell with PV100 logo
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip

    Red Jacket: Peyton Howell

    The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

    PharmaVoice staff • Sept. 15, 2022
  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Image attribution tooltip

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

    PharmaVoice staff • Sept. 15, 2022
  • Fabio Gratton header with PV100 logo
    Image attribution tooltip
    Permission granted by Fabio Gratton
    Image attribution tooltip

    Red Jacket: Fabio Gratton

    The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

    PharmaVoice staff • Sept. 15, 2022
  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Image attribution tooltip

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

    PharmaVoice staff • Sept. 15, 2022
  • A portrait of Dr. Yvonne Greenstreet framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Yvonne Greenstreet
    Image attribution tooltip

    Disrupters: Dr. Yvonne Greenstreet

    The CEO of Alnylam — a leader in RNAi therapies — has the company at the top of its game scientifically and culturally.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of WeiQing Zhou framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by WeiQing Zhou
    Image attribution tooltip

    Entrepreneurs: WeiQing Zhou

    The COO has launched two jewels in the biotech world that complement each other while serving broader innovation goals throughout the industry. 

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Vincent Keunen framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Vincent Keunen
    Image attribution tooltip

    Entrepreneurs: Vincent Keunen

    With his unique platform, the  has built a bridge between patients, physicians and researchers around the world.  

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Trishna Bharadia framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Trishna Bharadia
    Image attribution tooltip

    Disrupters: Trishna Bharadia

    As a patient advocate, The Spark Global’s owner is transforming how pharma companies approach patient centricity.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Dr. Tania Small framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Tania Small
    Image attribution tooltip

    Disrupters: Dr. Tania Small

    GSK’s medical oncology head is paving the way for patient-driven drug development and more equitable care.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Steven Steinhubl framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Steven Steinhubl
    Image attribution tooltip

    Legacy Leaders: Dr. Steven Steinhubl

    The chief medical officer at physIQ is working at the intersection of healthcare, clinical trials and technology to deliver better, faster and more accurate treatments to patients around the globe.

    Karissa Waddick • Sept. 6, 2022
  • A portrait of Dr. Stephen Dale framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Stephen Dale
    Image attribution tooltip

    Innovators: Dr. Stephen Dale

    The CMO at Kura Oncology, a clinical-stage biopharma company, is charting a new course to deliver on the promise of precision medicine in oncology.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Simba Gill framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Simba Gill
    Image attribution tooltip

    Disrupters: Simba Gill

    The CEO of Evelo Biosciences is going where no one else in biotech has gone before.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Shanthi Ganeshan framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Shanthi Ganeshan
    Image attribution tooltip

    Innovators: Shanthi Ganeshan

    The longtime regulatory pro has used innovative strategies to deliver emerging oncology therapies to patients from her position as head of regulatory affairs at Stemline.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Sebastian Guth framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sebastian Guth
    Image attribution tooltip

    DE&I Champions: Sebastian Guth

    Bayer Pharmaceuticals’ president, Americas Region, is driving equality efforts both within the company and for patients.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Scott Gray framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Scott Gray
    Image attribution tooltip

    DE&I Champions: Scott Gray

    The CEO, founder and president of Clincierge is championing diversity and inclusion within the company and beyond.

    Meagan Parrish • Sept. 6, 2022
  • A portrait of Sastry Chilukuri framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sastry Chilukuri
    Image attribution tooltip

    Tech Wizards: Sastry Chilukuri

    The co-CEO of Medidata is ushering in the next generation of clinical trial advancements, making research easier and more patient-focused than ever before.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sarah Hersey framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sarah Hersey
    Image attribution tooltip

    Innovators: Sarah Hersey

    At Bristol Myers Squibb, Sarah Hersey challenges the norm — and herself — to continually bring the best solutions to patients as vice president of translational sciences and diagnostics.

    Alexandra Pecci • Sept. 6, 2022
  • A portrait of Samantha Singer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Samantha Singer
    Image attribution tooltip

    Disrupters: Samantha Singer

    Abata’s CEO is stepping into the ring to fight for patients with progressive MS and other autoimmune disorders.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Sally Allain framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Sally Allain
    Image attribution tooltip

    Disrupters: Sally Allain

    The newest location for Johnson & Johnson Innovation’s incubator JLABS is in Washington, D.C., and the head of the cutting-edge space is bringing a diverse set of disruptive companies together.

    Michael Gibney • Sept. 6, 2022
  • A portrait of Rosalind Brewer framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Rosalind Brewer
    Image attribution tooltip

    Disrupters: Rosalind Brewer

    The CEO of Walgreens Boots Alliance is transforming the pharmacy powerhouse into a major new player in the healthcare space.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Rich Christie framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Rich Christie
    Image attribution tooltip

    Tech Wizards: Dr. Rich Christie

    Driven by an enthusiasm for invention and a connection between scientific expertise and patient outcomes, the AiCure chief medical officer looks to nurture AI-powered technology.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Renata Campos framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Renata Campos
    Image attribution tooltip

    DE&I Champions: Renata Campos

    Takeda's Growth and Emerging Markets Business Unit president is driving growth by doing what’s right for patients and her teams.

    PharmaVoice staff • Sept. 6, 2022
  • A portrait of Raymond Stevens framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Raymond Stevens
    Image attribution tooltip

    Legacy Leaders: Raymond Stevens

    The longtime pioneer in new drug discovery methods and founder of Structure Therapeutics has leveraged innovative science for commercial success.

    Meagan Parrish • Sept. 6, 2022